Infectious disease researchers ... PDGFA-associated protein 1 ... Dec. 13, 2024 — New research highlights the possibility of screening people with type 2 diabetes for liver damage at the same ...

More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients and Present Updated ...

Beam is pursuing a long-term, staged development strategy for sickle cell disease that includes three “waves” of ...

About 20% of individuals with fatty liver disease have a severe form of the disease, called metabolic dysfunction-associated steatohepatitis (MASH), that greatly increases the risk of HCC.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

A Cleveland Clinic liver specialist discusses the life expectancy with fatty liver disease and provides tips to take charge of your health. According to the American Liver Foundation, a nonprofit ...

In September 2023, The US Food and Drug Administration has approved Krystal Biotech’s Investigational New Drug (IND) ...

We contacted 80 tertiary referral hospitals for AILD in Europe via the European Reference Network 101 on Hepatological Diseases (ERN RARE-LIVER) as depicted in Figure 1. Fourteen centers treated ...

Human T-cell leukemia virus type 1 (HTLV-1) is a replication-competent human retrovirus associated with two distinct types of diseases: a malignancy of mature CD4 + T cells called adult T-cell ...

Alpha-1 antitrypsin (AAT) deficiency is a rare genetic disorder that is passed on in families and can affect the lungs, liver and/or skin. When this condition affects the lungs, it causes COPD ...